A number of case studies of HIV-1-infected individuals with NSCLC or malignant melanoma who were treated with nivolumab or ipilimumab (anti-CTLA4) reported changes in HIV-1 RNA or DNA [17–19,59]. This evidence concerns the gene CTLA4 and non-small cell lung carcinoma.